Keybank National Association OH Decreases Stock Holdings in Solventum Co. (NYSE:SOLV)

Keybank National Association OH reduced its position in shares of Solventum Co. (NYSE:SOLV) by 5.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 42,386 shares of the company’s stock after selling 2,258 shares during the period. Keybank National Association OH’s holdings in Solventum were worth $2,800,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. SBI Securities Co. Ltd. purchased a new stake in shares of Solventum during the 4th quarter worth $544,000. Jones Financial Companies Lllp lifted its position in Solventum by 14.2% in the fourth quarter. Jones Financial Companies Lllp now owns 3,366 shares of the company’s stock valued at $222,000 after acquiring an additional 418 shares during the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in Solventum in the fourth quarter valued at $317,000. Metis Global Partners LLC lifted its position in Solventum by 6.3% in the fourth quarter. Metis Global Partners LLC now owns 4,728 shares of the company’s stock valued at $312,000 after acquiring an additional 280 shares during the last quarter. Finally, Terril Brothers Inc. purchased a new stake in Solventum in the fourth quarter valued at $5,341,000.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on SOLV shares. Bank of America boosted their price target on shares of Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 26th. Mizuho boosted their price target on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research report on Monday. Piper Sandler lifted their price objective on shares of Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday, February 28th. Wells Fargo & Company lifted their price objective on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Finally, The Goldman Sachs Group lifted their price objective on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research note on Monday. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $79.86.

Solventum Stock Down 2.8 %

SOLV stock opened at $75.69 on Friday. The company has a market cap of $13.08 billion and a P/E ratio of 27.52. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $85.92. The company’s 50-day moving average price is $73.42 and its 200 day moving average price is $70.42. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.